These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 2822899

  • 1. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ, Nunan L, Porreca F.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [Abstract] [Full Text] [Related]

  • 2. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ, Nunan L, Porreca F.
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [Abstract] [Full Text] [Related]

  • 3. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
    Sheldon RJ, Nunan L, Porreca F.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):229-35. PubMed ID: 2836207
    [Abstract] [Full Text] [Related]

  • 4. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 09; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 5. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug 09; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul 09; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 7. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE, Lemcke PK, Gehrig CA, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1989 Apr 09; 249(1):83-90. PubMed ID: 2540324
    [Abstract] [Full Text] [Related]

  • 8. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC, Fujimoto JM.
    J Pharmacol Exp Ther; 1989 Jun 09; 249(3):762-8. PubMed ID: 2567350
    [Abstract] [Full Text] [Related]

  • 9. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ, Członkowski A, Lipkowski A, Herz A.
    J Pharmacol Exp Ther; 1989 Oct 09; 251(1):342-50. PubMed ID: 2571723
    [Abstract] [Full Text] [Related]

  • 10. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan 09; 260(1):334-42. PubMed ID: 1309877
    [Abstract] [Full Text] [Related]

  • 11. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan 09; 260(1):327-33. PubMed ID: 1309876
    [Abstract] [Full Text] [Related]

  • 12. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
    Werling LL, McMahon PN, Cox BM.
    J Pharmacol Exp Ther; 1988 Dec 09; 247(3):1103-6. PubMed ID: 2849659
    [Abstract] [Full Text] [Related]

  • 13. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May 09; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 14. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A.
    J Pharmacol Exp Ther; 1989 Mar 09; 248(3):1269-75. PubMed ID: 2539460
    [Abstract] [Full Text] [Related]

  • 15. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE, Pelton JT, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Nov 09; 243(2):492-500. PubMed ID: 2824748
    [Abstract] [Full Text] [Related]

  • 16. Differential antagonism of mu agonists by U50,488H in the rat.
    Porreca F, Tortella FC.
    Life Sci; 1987 Dec 07; 41(23):2511-6. PubMed ID: 2824958
    [Abstract] [Full Text] [Related]

  • 17. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    Gué M, Junien JL, Bueno L.
    J Pharmacol Exp Ther; 1989 Sep 07; 250(3):1006-10. PubMed ID: 2550612
    [Abstract] [Full Text] [Related]

  • 18. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
    Jiang Q, Sheldon RJ, Porreca F.
    J Pharmacol Exp Ther; 1990 May 07; 253(2):784-90. PubMed ID: 2160010
    [Abstract] [Full Text] [Related]

  • 19. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL, Shea-Donohue T.
    J Pharmacol Exp Ther; 1990 Jun 07; 253(3):1010-6. PubMed ID: 1972746
    [Abstract] [Full Text] [Related]

  • 20. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    Hong EK, Takemori AE.
    J Pharmacol Exp Ther; 1989 Nov 07; 251(2):594-8. PubMed ID: 2553928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.